Submissions from 2023
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity, Raymond S. Douglas, Steven Couch, Sara T. Wester, Brian T. Fowler, Catherine Y. Liu, Prem S. Subramanian, Rosa Tang, Quang T. Nguyen, Robi N. Maamari, Shoaib Ugradar, Kate Hsu, Michael Karon, and Marius N. Stan
Triage of Emergent Large Vessel Occlusion (ELVO) patients directly to Comprehensive Stroke Centers (CSCs) is good practice and benefits patients in Urban and Suburban population Centers - New insights from the TRIAGE-STROKE and RACECAT studies, David Fiorella, Tudor G. Jovin, Adam S. Arthur, Raul Nogueira, Adnan H. Siddiqui, Joshua A. Hirsch, and Felipe C. Albuquerque
Communication with physicians and family about breast Cancer recurrence, Kimberly M. Kelly, Pragya Rai, Jamie L. Studts, Stephanie Dickinson, Beate Henschel, Mark Dignan, Mara Chambers, and Hannah Hazard-Jenkins
Introduction to human-machine interface, Shama Mujawar, Aarohi Deshpande, Aarohi Gherkar, Samson Eugin Simon, and Bhupendra Prajapati
Ertugliflozin and hospitalization for heart failure across the spectrum of pre-trial ejection fraction: post-hoc analyses of the VERTIS CV trial, Ambarish Pandey, Ahmed A. Kolkailah, Francesco Cosentino, Christopher P. Cannon, Robert C. Frederich, David Z.I. Cherney, Samuel Dagogo-Jack, Richard E. Pratley, Nilo B. Cater, Ira Gantz, James P. Mancuso, and Darren K. McGuire
Amphiphilic small molecule antimicrobials: From cationic antimicrobial peptides (CAMPs) to mechanism-related, structurally-diverse antimicrobials, Jiani Yuan, Jiaxing Wang, Xiaoxue Li, Ya Zhang, Jinghong Xian, Chengdi Wang, Jifa Zhang, and Chengyong Wu